Serevent
Serevent is a medicine authorised by Swissmedic under authorisation number 57169. The authorisation holder is GlaxoSmithKline AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 25 January 2005 and the authorisation is valid without a time limit. ATC code R03AC12 places the medicine in the group Drugs for obstructive airway diseases.
| Authorisation number | 57169 |
|---|---|
| Name | Serevent |
| Full name | Serevent, Dosier-Aerosol |
| Authorisation holder | GlaxoSmithKline AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | R03AC12 |
| First authorisation | 25 January 2005 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Serevent, Dosier-Aerosol | B | 25 January 2005 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 120 | Inhalationen | R03AC12 | 03.04.3. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Serevent authorised in Switzerland?
Yes. Serevent is authorised by Swissmedic under authorisation number 57169, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Serevent have?
Serevent is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Serevent?
The authorisation holder is GlaxoSmithKline AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.